Fase 3 onderzoek ter evaluatie van REVLIMID bij patinten met hoog-risico smeulend multipel myeloom gepresenteerd bij ASH

Show Health and Fitness Publications

Tue, December 20, 2011

[ Tue, Dec 20th 2011 ] - Market Wire

Mylan Receives WHO Approval for Innovative 'Second-Line-in-a-Box' HIV/AIDS Treatment

[ Tue, Dec 20th 2011 ] - Market Wire

Warnex to Sell Its Analytical Services Division

[ Tue, Dec 20th 2011 ] - Market Wire

Implant Sciences' Quantum Sniffer QS-B220 Receive .. for TSA Air Cargo Screening Qualification Testin

[ Tue, Dec 20th 2011 ] - Market Wire

Covidien annuncia marchio CE per software Nellcora" Respiration Rate

[ Tue, Dec 20th 2011 ] - Market Wire

Agenus and NewVac Enter Into Agreement in the Area of Personalized Cancer Vaccines

[ Tue, Dec 20th 2011 ] - Market Wire

Covidien annonce le marquage CE de son logiciel N .. cora" de surveillance de la frquence respiratoire

[ Tue, Dec 20th 2011 ] - Market Wire

Covidien meldet CE-Kennzeichnung fr Nellcora" Respiration Rate Software

Mon, December 19, 2011

[ Mon, Dec 19th 2011 ] - Market Wire

TPI Attends 30th J.P. Morgan Healthcare Conference at San Francisco

[ Mon, Dec 19th 2011 ] - Market Wire

Health Management Associates Names Mike Fencel as .. Chief Executive Officer of North Florida Division

[ Mon, Dec 19th 2011 ] - Market Wire

Life Technologies to Present at Upcoming Investment Conferences in January

[ Mon, Dec 19th 2011 ] - Market Wire

The Law Firm of Levi & Korsinsky, LLP Launches an .. Securities Laws Violations by Invacare Corporatio

[ Mon, Dec 19th 2011 ] - Market Wire

Bronstein, Gewirtz & Grossman, LLC Announces Investigation into Invacare Corporation

[ Mon, Dec 19th 2011 ] - Market Wire

Imaging Diagnostic Systems Assigns ID-Matrix Systems as Exclusive Distributor for China

[ Mon, Dec 19th 2011 ] - Market Wire

Southern California Investment Forum Hosts an Inv .. hering Today at the Pacific Club in Newport Beach

[ Mon, Dec 19th 2011 ] - Market Wire

BioElectronics Announces Chinese Patent

[ Mon, Dec 19th 2011 ] - Market Wire

Unigene's 2011 Year in Review - Key Elements in Place to Address Debt in 2012

[ Mon, Dec 19th 2011 ] - Market Wire

Zimmer Initiates Quarterly Dividend and Announces New Share Repurchase Program

[ Mon, Dec 19th 2011 ] - Market Wire

Kindred Healthcare Promotes Patricia M. Henry to President of RehabCare Division

[ Mon, Dec 19th 2011 ] - Market Wire

Vermillion Completes the Acquisition of Correlogic Systems' Ovarian Cancer Diagnostics Business

[ Mon, Dec 19th 2011 ] - Market Wire

Cytori Completes IDE Filing for Chronic Myocardial Ischemia ATHENA Trial of the Celution(R) System

[ Mon, Dec 19th 2011 ] - Market Wire

Valeant Pharmaceuticals Completes Acquisition of Dermik

[ Mon, Dec 19th 2011 ] - Market Wire

Ardea Biosciences Initiates Phase 3 Clinical Development Program for Lesinurad

[ Mon, Dec 19th 2011 ] - Market Wire

Galectin Therapeutics Provides Corporate Update

[ Mon, Dec 19th 2011 ] - Market Wire

Somaxon Pharmaceuticals Hires Financial Advisor to Assist in Seeking Strategic Alternatives

[ Mon, Dec 19th 2011 ] - Market Wire

Isis Initiates Phase 1 Clinical Study of ISIS-SMNRx in Patients With Spinal Muscular Atrophy

[ Mon, Dec 19th 2011 ] - Market Wire

Equity Research on St. Jude Medical Inc. and Medt .. nt Cutbacks Affecting Medical Appliances &;

[ Mon, Dec 19th 2011 ] - Market Wire

Leading U.S. Healthcare Providers Ordering Sequenom Center for Molecular Medicine's MaterniT21 LDT

[ Mon, Dec 19th 2011 ] - Market Wire

Pharmacyclics Inc. Receives Issue Notice of Significant Bruton's Tyrosine Kinase (BTK) Patent

[ Mon, Dec 19th 2011 ] - Market Wire

PDL BioPharma Provides Fourth Quarter 2011 Revenue Guidance of $72 Million

[ Mon, Dec 19th 2011 ] - Market Wire

Pacira Pharmaceuticals, Inc. Announces Results fr .. Trial Published in Diseases of the Colon & Rectum

[ Mon, Dec 19th 2011 ] - Market Wire

DDC, One of the Largest DNA Testing Companies Wor .. the Acquisition of Orchid Cellmark's Government P

[ Mon, Dec 19th 2011 ] - Market Wire

Perceptive Informatics DataLabs EDC Solution Impl .. 15 of the Top Global Biopharmaceutical Companies

Sun, December 18, 2011

[ Sun, Dec 18th 2011 ] - Market Wire

Galapagos achieves clinical Proof-of-Mechanism milestone in GSK alliance

Sat, December 17, 2011

[ Sat, Dec 17th 2011 ] - Market Wire

Bull & Lifshitz, LLP Announces Investigation of Synovis Life Technologies, Inc.

Fri, December 16, 2011

[ Fri, Dec 16th 2011 ] - Market Wire

HealthSouth to Present at the 30th Annual J.P. Morgan Healthcare Conference

[ Fri, Dec 16th 2011 ] - Market Wire

Mylan Launches Generic Version of Toprol-XL Tablets

[ Fri, Dec 16th 2011 ] - Market Wire

Herbalife statement regarding Belgian Commercial Court Ruling

[ Fri, Dec 16th 2011 ] - Market Wire

St. Jude Medical meldt eerste implantatie in Euro .. ch onderzoek naar Portico transcatheter aortaklep

[ Fri, Dec 16th 2011 ] - Market Wire

Genomsequenzierung frdert Forschung auf dem Gebie .. weit verbreiteten Volkskrankheiten in Frankreich.

[ Fri, Dec 16th 2011 ] - Market Wire

Humana Military Makes the Holidays Brighter for Children

[ Fri, Dec 16th 2011 ] - Market Wire

ARIAD Announces Underwritersa Exercise of Over-Allotment Option

[ Fri, Dec 16th 2011 ] - Market Wire

Dehaier Medical Enters European Homecare Medical Product Market

[ Fri, Dec 16th 2011 ] - Market Wire

Landmark Publication Endorses Prana's Drug Pipeli .. Strategy for Treating Neurodegenerative Diseases

[ Fri, Dec 16th 2011 ] - Market Wire

Ariad, Delta Air Lines, BioSante, Bank of America, Boston Scientific and News Corp

[ Fri, Dec 16th 2011 ] - Market Wire

Catasys Adds Another Customer in Massachusetts

[ Fri, Dec 16th 2011 ] - Market Wire

AtriCureas Synergy Ablation System Receives FDA Approval for the Treatment of Atrial Fibrillation

[ Fri, Dec 16th 2011 ] - Market Wire

Underperforming Medtronic and Allezoe Medical Look to Turn Around Fortunes in 2012

[ Fri, Dec 16th 2011 ] - Market Wire

Recent FDA Approvals for Antares Pharma and Boston Scientific Have Done Little to Boost Shares

[ Fri, Dec 16th 2011 ] - Market Wire

China Sky One Medical to Jointly Launch Adult Stem Cell Research Enterprise

[ Fri, Dec 16th 2011 ] - Market Wire

Trimel to Present Anorgasmia (FSD) Phase II Clinical Trial Results

[ Fri, Dec 16th 2011 ] - Market Wire

Valeant Pharmaceuticals Proposes to Acquire ISTA Pharmaceuticals Inc. for $6.50 Per Share in Cash

[ Fri, Dec 16th 2011 ] - Market Wire

Kensey Nash to Enter Into Mediation with St. Jude Medical over Angio-Seal Contract Disputes

[ Fri, Dec 16th 2011 ] - Market Wire

Pfizer Broadens and Extends Commitment to Help Pr .. Infants and Young Children in the Worldas Poores

[ Fri, Dec 16th 2011 ] - Market Wire

Thoratec Announces Appointment of William A. Hawkins to Board of Directors

[ Fri, Dec 16th 2011 ] - Market Wire

Valeant Announces Successful Results From Phase III Onychomycosis Trials

[ Fri, Dec 16th 2011 ] - Market Wire

La secuenciacin del genoma ayuda a la investigacin de las enfermedades pblicas en Francia

[ Fri, Dec 16th 2011 ] - Market Wire

Concord Medical to Present at the 30th Annual J.P. Morgan Healthcare Conference in January 2012

[ Fri, Dec 16th 2011 ] - Market Wire

Centene Corporation Announces 2012 Financial Guidance

Thu, December 15, 2011

[ Thu, Dec 15th 2011 ] - Market Wire

Die US-Arzneimittelbehrde FDA hat einem beschleun .. KALYDECOa" (Ivacaftor) zugestimmt, das erste pote

[ Thu, Dec 15th 2011 ] - Market Wire

Pomerantz Law Firm Investigates Claims on Behalf of Investors of SonoSite, Inc.

[ Thu, Dec 15th 2011 ] - Market Wire

The Law Firm of Levi &;; Korsinsky, LLP .. of Breaches of Fiduciary Duty by the Board of Sy

[ Thu, Dec 15th 2011 ] - Market Wire

Rigrodsky & Long, P.A. Announces Investigation of .. ite, Inc.as Sale to Fujifilm Holdings Corporation

[ Thu, Dec 15th 2011 ] - Market Wire

St. Jude gibt erste Implantation der Transkathete .. ahmen einer europischen klinischen Studie bekannt

[ Thu, Dec 15th 2011 ] - Market Wire

Orexigen Therapeutics Prices Public Offering of Common Stock and Warrants to Purchase Common Stock

[ Thu, Dec 15th 2011 ] - Market Wire

Critical Stock Alerts for Eli Lilly, NVIDIA, Inte .. mana Gold, Charles Schwab, and MF Global Holdings

[ Thu, Dec 15th 2011 ] - Market Wire

Vista Partners Updates Coverage on ADVENTRX Pharmaceuticals, Inc.;; $3.50 Target Price

[ Thu, Dec 15th 2011 ] - Market Wire

TheraBiogen Announces National Cable Television Ad Campaign Launches YouTube Page

[ Thu, Dec 15th 2011 ] - Market Wire

p-Value Capital Management, LLC Comments on Results of Myrexis, Inc. Shareholder Vote

[ Thu, Dec 15th 2011 ] - Market Wire

Graymark Healthcare Closes Acquisition of Village Sleep Center in Plano, Texas

[ Thu, Dec 15th 2011 ] - Market Wire

New Management Changes Poise USANA for Further Growth

[ Thu, Dec 15th 2011 ] - Market Wire

Covidien meldt conference call en webcast

[ Thu, Dec 15th 2011 ] - Market Wire

Gruppo di ricerca per il linfoma negli adulti (GE .. LIMID per studio sul secondo tipo di linfoma pi c

[ Thu, Dec 15th 2011 ] - Market Wire

Covidien annuncia una teleconferenza e trasmissione web

[ Thu, Dec 15th 2011 ] - Market Wire

Arrowhead to Report Fiscal 2011 Fourth Quarter and Year-End Financial Results

[ Thu, Dec 15th 2011 ] - Market Wire

Covidien plant Ausgliederung des Unternehmensbereichs Pharmazeutika

[ Thu, Dec 15th 2011 ] - Market Wire

Covidien envisage une scission de sa branche Pharmacie

[ Thu, Dec 15th 2011 ] - Market Wire

Soligenix Initiates Next Generation Anthrax Vacci .. t Program Under Agreement With Harvard University

[ Thu, Dec 15th 2011 ] - Market Wire

SciClone Pharmaceuticals Announces Final Settlement of Stockholder Derivative Litigation

[ Thu, Dec 15th 2011 ] - Market Wire

Implant Sciences Sells Over $200,000 of Quantum S .. s Trace Detectors for Building Security in Mexico

[ Thu, Dec 15th 2011 ] - Market Wire

Importante grupo cooperativo de investigacin sobr .. elige REVLIMID para el estudio del segundo subtip

[ Thu, Dec 15th 2011 ] - Market Wire

Perceptive Informatics Completes Over 500 System .. Industry Continues to Adopt Seamless eClinical S

[ Thu, Dec 15th 2011 ] - Market Wire

Illumina Hires Laura Lauman as Vice President of Marketing

Wed, December 14, 2011

[ Wed, Dec 14th 2011 ] - Market Wire

Isis Adds Three New Drugs to Its Development Pipeline

[ Wed, Dec 14th 2011 ] - Market Wire

AVI BioPharma Receives NASDAQ Notice of Minimum Bid Price Non-Compliance

[ Wed, Dec 14th 2011 ] - Market Wire

Anthera Announces Completion of Safety Review by DSMB for VISTA-16

[ Wed, Dec 14th 2011 ] - Market Wire

BioSante Pharmaceuticals Announces Results from LibiGel Efficacy Trials

[ Wed, Dec 14th 2011 ] - Market Wire

Hospira to Present at the J.P. Morgan 30th Annual Healthcare Conference Jan. 10, 2012

[ Wed, Dec 14th 2011 ] - Market Wire

ViroPharma Announces Approval of Modernized Label .. Vancocin (vancomycin hydrochloride, USP) Capsules

[ Wed, Dec 14th 2011 ] - Market Wire

Positron's Attrius Receives Health Canada Approval

[ Wed, Dec 14th 2011 ] - Market Wire

AIM Honored for Innovative Program That Helps Consumers Make Better Choices About Their Care

[ Wed, Dec 14th 2011 ] - Market Wire

Vooraanstaande samenwerkingsgroep voor lymfoomond .. ) kiest REVLIMID voor onderzoek naar tweede meest

[ Wed, Dec 14th 2011 ] - Market Wire

Amica Mature Lifestyles Announces Closing of Subs .. cluding Exercise in Full of Over-Allotment Option

[ Wed, Dec 14th 2011 ] - Market Wire

Amgen Announces Final Results of Its Tender Offer

[ Wed, Dec 14th 2011 ] - Market Wire

St. Jude Medical annuncia il primo impianto nella .. clinica per la valutazione dalla valvola cardiac

[ Wed, Dec 14th 2011 ] - Market Wire

CytoSorbents Awarded US Army SBIR Trauma Grant

[ Wed, Dec 14th 2011 ] - Market Wire

Definitieve fase 2 gegevens van evaluatie REVLIMI .. et recidiverende of refractaire chronische lymfat

[ Wed, Dec 14th 2011 ] - Market Wire

Datos finales de la Fase II que evalan REVLIMID y .. eucemia linfoctica crnica recurrente o resistente

[ Wed, Dec 14th 2011 ] - Market Wire

Premiere Cooperative Group in Adult Lymphoma Rese .. for Study in Second Most Common Lymphoma Subtype

[ Wed, Dec 14th 2011 ] - Market Wire

Salix Pharmaceuticals Announces NDA Submission fo .. emer for the Treatment of HIV-Associated Diarrhea

[ Wed, Dec 14th 2011 ] - Market Wire

Meta-analysis of Five Clinical Trials including C .. T Study Published in American Journal of Obstetri

[ Wed, Dec 14th 2011 ] - Market Wire

REVLIMID evaluado en combinacin con rituximab com .. pacientes con leucemia linfoctica crnica no trata

[ Wed, Dec 14th 2011 ] - Market Wire

Presentados en ASH los datos de un estudio de Fas .. en pacientes con mieloma indolente de alto riesgo

[ Wed, Dec 14th 2011 ] - Market Wire

OncoSec Medical Engages The Investor Relations Group

[ Wed, Dec 14th 2011 ] - Market Wire

Rsultats dfinitifs de laessai de phase II valuant .. ez les patients atteints de leucmie lymphocytaire

[ Wed, Dec 14th 2011 ] - Market Wire

Threshold Pharmaceuticals Announces Promising Pha .. Trial Results in Patients With Advanced Leukemias

[ Wed, Dec 14th 2011 ] - Market Wire

REVLIMID a t valu en combinaison avec le Rituxima .. ntiel destin aux patients atteints de leucmie lym

Tue, December 13, 2011

[ Tue, Dec 13th 2011 ] - Market Wire

Bio-Path Holdingsa Initial Phase I Data in Leukem .. s That Its Neutral Lipid Delivery Technology Anti

[ Tue, Dec 13th 2011 ] - Market Wire

Direction of Market Influences - Report Highlight .. ceutical Industries Ltd (ADR) and Sanofi SA (ADR)

[ Tue, Dec 13th 2011 ] - Market Wire

GenVec President and Chief Executive Officer Announces Retirement

[ Tue, Dec 13th 2011 ] - Market Wire

China Botanic Announces Development of New Siberian Ginseng Polysaccharide Extract Powder

[ Tue, Dec 13th 2011 ] - Market Wire

Fase 2-onderzoek evalueert klinisch profijt van p .. j eerder behandelde patinten met multipel myeloom

[ Tue, Dec 13th 2011 ] - Market Wire

Endgltige Daten aus multizentrischer Phase-II-Stu .. binationstherapie von VIDAZA und REVLIMID fr MDS-

[ Tue, Dec 13th 2011 ] - Market Wire

Nektar Announces Positive Clinical Data from Seco .. NKTR-181, a Novel Opioid Analgesic Molecule to Tr

[ Tue, Dec 13th 2011 ] - Market Wire

Stem Cell Therapeutics Announces Additions to Advisory Board

[ Tue, Dec 13th 2011 ] - Market Wire

Eindgegevens van Fase II multi-center onderzoek n .. REVLIMID bij patinten met hoogrisico MDS gepresen

[ Tue, Dec 13th 2011 ] - Market Wire

BioLineRx to Develop and Commercialize Novel Peptide Drug Candidates Discovered by Compugen

[ Tue, Dec 13th 2011 ] - Market Wire

Synergy Pharmaceuticals, Inc. reicht Klage ein ge .. Inc. und dessen Chief Scientific Officer und Sen

[ Tue, Dec 13th 2011 ] - Market Wire

Prsentation laASH des rsultats dfinitifs daune tu .. I valuant la combinaison de VIDAZA et de REVLIMID

[ Tue, Dec 13th 2011 ] - Market Wire

Une tude de phase III avec traitement continu de .. ion statistiquement considrable de la survie sans

[ Tue, Dec 13th 2011 ] - Market Wire

Phase-III-Studie mit kontinuierlicher REVLIMID-Th .. ifikante Verbesserung der progressionsfreien berl

[ Tue, Dec 13th 2011 ] - Market Wire

Threshold Pharmaceuticals Announces Update to TH- .. resented at the Oppenheimer Healthcare Conference

[ Tue, Dec 13th 2011 ] - Market Wire

NTRR Targets $390 Billion Weight Loss and Diet Management Market

[ Tue, Dec 13th 2011 ] - Market Wire

FDA Psychopharmacologic Drugs Advisory Committee Recommends Approval of Alexza's ADASUVEa"

[ Tue, Dec 13th 2011 ] - Market Wire

Radient Pharmaceuticals Launches New Onko-Sure Website, Facebook and Twitter Outreach

[ Tue, Dec 13th 2011 ] - Market Wire

Une tude de dosage value REVLIMID chez des patien .. aits, atteints de leucmie lymphocytaire chronique

[ Tue, Dec 13th 2011 ] - Market Wire

Les rsultats d'une analyse comparative rvlent que .. tistiquement significative le risque de dcs, sans

[ Tue, Dec 13th 2011 ] - Market Wire

Synergy Pharmaceuticals, Inc. dpose plainte contr .. Inc. et son conseiller scientifique en chef et VP

[ Tue, Dec 13th 2011 ] - Market Wire

Synergy Pharmaceuticals, Inc. Files Suit Against .. c. and its Chief Scientific Officer and Senior VP

[ Tue, Dec 13th 2011 ] - Market Wire

Synergy Pharmaceuticals, Inc. fa causa ad Ironwoo .. suo Direttore Scientifico e Vicepresidente Senior

[ Tue, Dec 13th 2011 ] - Market Wire

Synergy Pharmaceuticals, Inc. spant geding aan te .. , Inc. en haar Chief Scientific Officer en Senior

Mon, December 12, 2011

[ Mon, Dec 12th 2011 ] - Market Wire

Abiomed 2011 Investor Day Webcast Replay Available

[ Mon, Dec 12th 2011 ] - Market Wire

First FDA-Approved Treatment for Myelofibrosis, J .. ssed in Multiple Presentations at 2011 ASH Annual

[ Mon, Dec 12th 2011 ] - Market Wire

Paladin Labs Announces the Canadian Launch of DigiFab(TM) Digoxin Immune Fab (Ovine)

[ Mon, Dec 12th 2011 ] - Market Wire

Celldex Therapeutics Presents Novel Preclinical D .. erican Society of Hematology Meeting in San Diego

[ Mon, Dec 12th 2011 ] - Market Wire

Synageva BioPharma to Present at the 30th Annual .. Morgan Healthcare Conference on January 11, 2012

[ Mon, Dec 12th 2011 ] - Market Wire

Amica Mature Lifestyles to Announce Second Quarte .. Results and Host Conference Call January 16, 2012

[ Mon, Dec 12th 2011 ] - Market Wire

Theravance Announces Initiation of Phase 2 Study .. ARIN Compound, TD-9855, for the Treatment of ADHD

[ Mon, Dec 12th 2011 ] - Market Wire

Lilly Oncology Reveals Findings From Study of JAK2 Inhibitor for Blood Cancers at ASH Meeting

[ Mon, Dec 12th 2011 ] - Market Wire

Community Health Systems Announces Definitive Agreement to Acquire Blue Island, Illinois Hospital

[ Mon, Dec 12th 2011 ] - Market Wire

Health Canada Approves Feraheme (ferumoxytol) to .. ency Anemia in Adults with Chronic Kidney Disease

[ Mon, Dec 12th 2011 ] - Market Wire

AMAG Pharmaceuticals Announces Preliminary Data R .. acy of a Single Infusion of 1020 mg Ferumoxytol (

[ Mon, Dec 12th 2011 ] - Market Wire

Nektar Therapeutics Initiates Phase 3 BEACON Tria .. f NKTR-102 in Women with Metastatic Breast Cancer

[ Mon, Dec 12th 2011 ] - Market Wire

ProMetic Announces Achievement of Significant Targeted Milestone With a Multinational Company

[ Mon, Dec 12th 2011 ] - Market Wire

PDL BioPharma Announces Departure of Chief Financial Officer

[ Mon, Dec 12th 2011 ] - Market Wire

Geron Initiates Phase 2 Trial of GRN1005 in Brain Metastases From Breast Cancer

[ Mon, Dec 12th 2011 ] - Market Wire

Mylan Names John Thievon President of Dey Pharma

[ Mon, Dec 12th 2011 ] - Market Wire

Soligenix Announces Publication of Results of its .. al Trial of orBec in the Prevention of Acute GVHD

[ Mon, Dec 12th 2011 ] - Market Wire

MELA Sciences Announces Additions to Board of Directors

[ Mon, Dec 12th 2011 ] - Market Wire

Emergent BioSolutions to Participate in January 2012 Investor Conferences

[ Mon, Dec 12th 2011 ] - Market Wire

PDL BioPharma Corrects Its Adjusted Conversion Rates for Its Convertible Notes

[ Mon, Dec 12th 2011 ] - Market Wire

Kraig Biocraft Laboratories Receives New Custom Z .. er Configurations for Advanced Fibers Development

[ Mon, Dec 12th 2011 ] - Market Wire

Abbott and Reata Pharmaceuticals Announce Agreeme .. ze Next-Generation Antioxidant Inflammation Modul

[ Mon, Dec 12th 2011 ] - Market Wire

10-Year Study Demonstrates IRIDEX MicroPulsea" La .. ffective for Patients with Diabetic Macular Edema

[ Mon, Dec 12th 2011 ] - Market Wire

Inovio Pharmaceuticals to Present at Oppenheimer Investor Conference

Sun, December 11, 2011

[ Sun, Dec 11th 2011 ] - Market Wire

Pharming granted U.S. patent on C1 inhibitor use in ischemia reperfusion injury indications

[ Sun, Dec 11th 2011 ] - Market Wire

Onyx Pharmaceuticals Announces FDA Standard Revie .. New Drug Application for the Treatment of Relapse

Sat, December 10, 2011

[ Sat, Dec 10th 2011 ] - Market Wire

Onyx Pharmaceuticals Provides Update on Carfilzom .. 3rd American Society of Hematology Annual Meeting

[ Sat, Dec 10th 2011 ] - Market Wire

Brower Piven Encourages Investors Who Have Losses .. nvestment in Pain Therapeutics, Inc. to Inquire A

[ Sat, Dec 10th 2011 ] - Market Wire

Gilead annuncia i dati raccolti in due anni nella .. le di Fase III su elvitegravir,;;;

[ Sat, Dec 10th 2011 ] - Market Wire

Gilead annuncia i dati raccolti in due anni nella .. le di Fase III su elvitegravir,;;;

[ Sat, Dec 10th 2011 ] - Market Wire

Gilead annuncia i dati raccolti in due anni nella .. le di Fase III su elvitegravir,;;;

[ Sat, Dec 10th 2011 ] - Market Wire

Gilead annuncia i dati raccolti in due anni nella .. le di Fase III su elvitegravir,;;; u

[ Sat, Dec 10th 2011 ] - Market Wire

Gilead annuncia i dati raccolti in due anni nella .. le di Fase III su elvitegravir,;;;

[ Sat, Dec 10th 2011 ] - Market Wire

Gilead annuncia i dati raccolti in due anni nella .. le di Fase III su elvitegravir,;;;

[ Sat, Dec 10th 2011 ] - Market Wire

Abiomed Announces Expanded Heart Recovery Strategy with Multi Year Growth Initiatives

[ Sat, Dec 10th 2011 ] - Market Wire

Exact Sciences Announces Successful Completion of Public Offering of Common Stock

[ Sat, Dec 10th 2011 ] - Market Wire

Gilead maakt tweejaarsgegevens bekend van crucial .. ie van elvitegravir, een integraseremmer voor hiv

[ Sat, Dec 10th 2011 ] - Market Wire

Gilead gibt Zweijahresdaten der Phase-3-Pivotstud .. itegravir, einem Integrasehemmer bei HIV, bekannt

[ Sat, Dec 10th 2011 ] - Market Wire

Gilead annuncia i dati raccolti in due anni nella .. le di Fase III su elvitegravir, un inibitore dell

[ Sat, Dec 10th 2011 ] - Market Wire

Data Shows Medtronic AdaptiveStima" with RestoreSensora" Provides Pain Relief and Convenience

[ Sat, Dec 10th 2011 ] - Market Wire

Gilead Announces Two-Year Data From Pivotal Phase .. y of Elvitegravir, an Integrase Inhibitor for HIV

Fri, December 9, 2011

[ Fri, Dec 09th 2011 ] - Market Wire

Saxena White P.A. Files a Securities Fraud Class Action Against Hospira, Inc.

[ Fri, Dec 09th 2011 ] - Market Wire

Leading Addiction Expert Joins Catasys as Chief Medical Officer

[ Fri, Dec 09th 2011 ] - Market Wire

Kahn Swick & Foti, LLC Announces Investigation in .. Report of Possible Federal Manufacturing Suspens

[ Fri, Dec 09th 2011 ] - Market Wire

HealthSpring, Inc. Announces Record Date and Meet .. of Stockholders in Connection with the Proposed M

[ Fri, Dec 09th 2011 ] - Market Wire

Amgen to Present at the 22nd Annual Oppenheimer Healthcare Conference

[ Fri, Dec 09th 2011 ] - Market Wire

Warnex Sells Its Medical and Forensic Testing Ope .. Reaches Repayment Agreement With Its Debentureho

[ Fri, Dec 09th 2011 ] - Market Wire

Shengtai Pharmaceutical, Inc. Announces Annual Meeting Date

[ Fri, Dec 09th 2011 ] - Market Wire

Abbott Declares 352nd Consecutive Quarterly Dividend

[ Fri, Dec 09th 2011 ] - Market Wire

Thoratec Presentation at Oppenheimer Conference to Be Webcast

[ Fri, Dec 09th 2011 ] - Market Wire

HeartWare to Present at the Oppenheimer 22nd Annual Healthcare Conference

[ Fri, Dec 09th 2011 ] - Market Wire

Quest Diagnostics Care360a" Named Top e-Prescribing Platform by Black Book Rankings

[ Fri, Dec 09th 2011 ] - Market Wire

Lilly for Better Healtha" Expands Website to Incl .. Spanish Health Information and Interactive Tools

[ Fri, Dec 09th 2011 ] - Market Wire

AVI BioPharma Names Jayant Aphale, Ph.D., Senior Vice President of Technical Operations

[ Fri, Dec 09th 2011 ] - Market Wire

VentriPoint Announces Proposed Issuance of Shares for Debt and Credit Facility

[ Fri, Dec 09th 2011 ] - Market Wire

Rosetta Genomics Announces New York State Approval for miRview mets?

[ Fri, Dec 09th 2011 ] - Market Wire

Edwards Lifesciences Forecasts Strong Sales and Earnings Growth in 2012

[ Fri, Dec 09th 2011 ] - Market Wire

CytoSorbents Announces Purchase Agreement for up to $8.5 Million With Lincoln Park Capital

[ Fri, Dec 09th 2011 ] - Market Wire

ULURU Inc. Receives Notice From NYSE Amex Regarding Continued Listing Standards

[ Fri, Dec 09th 2011 ] - Market Wire

BioSpecifics Technologies Corp. Announces Appointment of George Gould to Board of Directors

[ Fri, Dec 09th 2011 ] - Market Wire

Smart-Tek Solutions, Inc. Projects Recoup and Possible Loss Exceeded by 4th Quarter's End

[ Fri, Dec 09th 2011 ] - Market Wire

Mindray Medical to Acquire a Controlling Stake in Zhejiang Greenlander Information Technology

[ Fri, Dec 09th 2011 ] - Market Wire

Aeterna Zentaris Presents Positive Preclinical Da .. 131, a Highly Selective Erk 1/2 Inhibitor, at San

[ Fri, Dec 09th 2011 ] - Market Wire

Hansen Medical Secures $30 Million Debt Facility

[ Fri, Dec 09th 2011 ] - Market Wire

OncoSec to Present at the 22nd Annual Oppenheimer Healthcare Conference

Thu, December 8, 2011

[ Thu, Dec 08th 2011 ] - Market Wire

Enzon Presents Data From Phase II PEG-SN38 (EZN-2 .. ) Study in Patients With Metastatic Breast Cancer

[ Thu, Dec 08th 2011 ] - Market Wire

Zimmer Introduces New CLS Breviusa" Hip Stem with Kinectiv Technology in the United States

[ Thu, Dec 08th 2011 ] - Market Wire

VentriPoint Announces Proposed Issuance of Shares for Debt and Offering

[ Thu, Dec 08th 2011 ] - Market Wire

Janssen Biotech, Inc. Announces Collaborative Dev .. e Agreement for Investigational Anti-Cancer Drug,

[ Thu, Dec 08th 2011 ] - Market Wire

Insulet Corporation to Present at Upcoming Investor Conference

Fase 3 onderzoek ter evaluatie van REVLIMID bij patinten met hoog-risico smeulend multipel myeloom gepresenteerd bij ASH

_{//health-fitness.news-articles.net/content/2011/ .. lend-multipel-myeloom-gepresenteerd-bij-ash.html}
^{Published in Health and Fitness on Tuesday, December 13th 2011 at 14:15 GMT by Market Wire}

BOUDRY, Switzerland--([ BUSINESS WIRE ])--Celgene International Srl, een dochteronderneming van Celgene Corporation (NASDAQ: CELG), maakt bekend dat bijgewerkte gegevens ter evaluatie van continue behandeling met REVLIMID (lenalidomide) bij patinten met hoog-risico asymptomatisch smeulend multipel myeloom zijn gepresenteerd op de 53e jaarlijkse vergadering van de American Society of Hematology. Het onderzoek toonde aan dat vroegtijdige behandeling met lenalidomide en dexamethasone gevolgd door voortgezette behandeling met lenalidomide de tijd tot symptomatische ziekte vertraagde, en liet een verwacht overlevingsvoordeel zien ten opzichte van observatie. De driejarige totale overleving na opname was 93 procent bij behandeling met REVLIMID en dexamethasone, tegen 76 procent voor patinten alleen onder observatie.

Deze bekendmaking is officieel geldend in de originele brontaal. Vertalingen zijn slechts als leeshulp bedoeld en moeten worden vergeleken met de tekst in de brontaal welke als enige juridische geldigheid beoogt.

Publication Contributing Sources

Market Wire is a Trusted Source

Market Wire